Skip to main navigation
Skip to search
Skip to main content
Northwestern Scholars Home
Help & FAQ
Home
Experts
Organizations
Research Output
Grants
Core Facilities
Research Data
Search by expertise, name or affiliation
Targeting NKG2D/NKG2D ligand axis for cancer immunotherapy
Jennifer Wu
*
*
Corresponding author for this work
Urology
Research output
:
Chapter in Book/Report/Conference proceeding
›
Chapter
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Targeting NKG2D/NKG2D ligand axis for cancer immunotherapy'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Cancer Immunotherapy
100%
NKG2D
100%
T Cells
16%
Tumor Cells
8%
Natural Killer Cells
8%
CD4 T Cells
8%
Basic Biology
8%
NKT Cells
8%
Activation Receptor
8%
L-system
8%
Genomic Insult
8%
Biochemistry, Genetics and Molecular Biology
NKG2D
100%
Cancer Immunotherapy
100%
T Cell
25%
Natural Killer Cell
8%
CD4
8%
Natural Killer T Cell
8%
Genomics
8%
Material Science
T-Cells
100%
Tumor
33%